Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Bionova Scientific has initiated construction of its new biologics manufacturing facility.
read more
Bionova Scientific announced it has licensed ATUM's proprietary Leap-In Transposase® transposon-based gene delivery and its miCHO™ cell line development technologies.
read more
Bionova Scientific, a subsidiary of Asahi Kasei, announced the opening of a 10,000 square-foot plasmid DNA (pDNA) development and production facility in The Woodlands, Texas.
read more
Wednesday, November 25, 2020
Bionova Scientific announced it has secured its first client commitment for GMP clinical supply.
read more
Monday, November 14, 2022
BioNTech announced its Singapore affiliate BioNTech Pharmaceuticals Asia Pacific entered into an agreement with Novartis Singapore Pharmaceutical Manufacturing to acquire one of its GMP-certified manufacturing facilities. Supported by the Singapore ...
read more
Wednesday, September 23, 2020
BioNTech announced the signing of a share purchase agreement with Novartis AG, Basel / Switzerland to acquire their GMP certified manufacturing facility in Marburg, Germany.
read more
BioNTech SE has announced plans to expand its global footprint to Asia with the establishment of its Regional Headquarters for south east Asia in Singapore.
read more
Monday, September 21, 2020
BioNTech will receive a grant by the German Federal Ministry of Education and Research to support the accelerated development of SARS-CoV-2 vaccines.
read more
Monday, December 07, 2020
BioNTech and InstaDeep announced a collaboration aimed at applying the latest advances in AI and ML technology to develop novel immunotherapies.
read more
Tuesday, February 18, 2014
BioOutsource Ltd. (“BioOutsource”), a global leader in biologics contract testing and biosimilar characterization for the biopharmaceutical industry, today announced the opening of a new Biosimilar Centre of Excellence in Glasgow. The new facility ...
read more
BioPharma Services USA, has been awarded a 5-year, $20 million contract with the Center for Drug Evaluation and Research (CDER), a division of the US Food and Drug Administration (FDA). The contract is to conduct in vivo studies of generic drug ...
read more
Wednesday, August 26, 2015
BioPharma Services has announced that its Toronto-based Bioanalytical Laboratory has successfully passed its first inspection by the Brazilian regulatory authority, ANVISA.
read more
BioPharma Services Inc. has announced that its Toronto-based clinical and bioanalytical site for Phase I/IIa clinical trials and bioequivalence studies has successfully completed an audit by the U.S. Food and Drug Administration (FDA).
read more
Monday, September 25, 2017
BioPharma Services has successfully completed its first year of collaboration with the CDER, a division of the FDA.
read more
BioPharma Services announced it has successfully completed three inspections this month by the FDA, with concurrent audits at both research centers in Toronto, Canada, and Columbia, Missouri.
read more